H.R. 7213 118th Congress
Autism CARES Act of 2024
- Became Public Law 118-180
- Health
- Sponsor: Christopher H. Smith
- Congress.gov ↗
Latest action, Dec 23, 2024: Became Public Law No: 118-180.
How the House voted: On Motion to Suspend the Rules and Concur in the Senate Amendment
Dec 16, 2024 · Passed · 374–15 (it needed 2/3)
- Yea (374)
- Nay (15)
- Didn't vote (40)
- Letters: party (D, R, I)
By party
- Democrat
- Republican
- Independent
Every roll call on it (2)
Each dot is a roll call, in order: how much of the House voted yea. The ringed one decided it.
- Carried
- Failed
See the data
| Date | Question | Result | Yea–nay |
|---|---|---|---|
| Dec 16, 2024 | On Motion to Suspend the Rules and Concur in the Senate Amendment | Passed | 374–15 |
| Sep 18, 2024 | On Motion to Suspend the Rules and Pass, as Amended | Passed | 402–13 |
61 cosponsors
Sponsored by Christopher H. Smith (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
39 D · 22 R
- Democrat
- Republican
- Independent
Referred to: House: Energy and Commerce Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
ABBOTT LABORATORIES
W STRATEGIES, LLC
8 reports
FUTURE OF PHARMACY COALITION LLC
ALSTON & BIRD LLP
8 reports
4 reports
4 reports
3 reports
CHILDREN'S HEALTHCARE OF ATLANTA
ARENTFOX SCHIFF LLP
3 reports
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
ARENTFOX SCHIFF LLP
3 reports
3 reports
2 reports
CENCORA, INC.
BALLARD SPAHR LLP
2 reports
THE O TEAM LLC (ON BEHALF OF AUTISM SPEAKS)
GEPHARDT GROUP GOVERNMENT AFFAIRS
2 reports
2 reports
ABBOTT LABORATORIES
KOUNTOUPES DENHAM CARR & REID, LLC
1 report
All 19 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | House |
|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | W STRATEGIES, LLC | 8 | $0 | Q1 2023 | Q3 2024 | yes |
| FUTURE OF PHARMACY COALITION LLC | ALSTON & BIRD LLP | 8 | $1.0M | Q1 2023 | Q3 2024 | yes |
| AUTISM SPEAKS | 4 | $240K | Q1 2024 | Q3 2024 | yes | |
| RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | 4 | $380K | Q1 2024 | Q3 2024 | yes | |
| WALGREEN COMPANY | 4 | $3.2M | Q1 2023 | Q3 2023 | yes | |
| ARC OF THE UNITED STATES | 3 | $130K | Q4 2024 | Q3 2024 | yes | |
| CHILDREN'S HEALTHCARE OF ATLANTA | ARENTFOX SCHIFF LLP | 3 | $0 | Q4 2024 | Q3 2024 | yes |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | ARENTFOX SCHIFF LLP | 3 | $0 | Q4 2024 | Q3 2024 | yes |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3 | $460K | Q4 2024 | Q3 2024 | yes | |
| TOURETTE ASSOCIATION OF AMERICA | 3 | $200K | Q4 2024 | Q3 2024 | yes | |
| AMERICAN ACADEMY OF PEDIATRICS | 2 | $340K | Q4 2024 | Q3 2024 | yes | |
| CENCORA, INC. | BALLARD SPAHR LLP | 2 | $0 | Q1 2023 | Q2 2023 | yes |
| THE O TEAM LLC (ON BEHALF OF AUTISM SPEAKS) | GEPHARDT GROUP GOVERNMENT AFFAIRS | 2 | $20K | Q2 2024 | Q3 2024 | yes |
| VANDERBILT UNIVERSITY MEDICAL CENTER | 2 | $120K | Q4 2024 | Q3 2024 | yes | |
| ABBOTT LABORATORIES | KOUNTOUPES DENHAM CARR & REID, LLC | 1 | $0 | Q1 2023 | Q1 2023 | yes |
| CVS HEALTH INC | BOCKORNY GROUP, INC. | 1 | $50K | Q1 2023 | Q1 2023 | yes |
| FORTA | GEPHARDT GROUP GOVERNMENT AFFAIRS | 1 | $20K | Q2 2024 | Q2 2024 | yes |
| NATIONAL DOWN SYNDROME CONGRESS | 1 | $0 | Q4 2024 | Q4 2024 | yes | |
| UNIVERSITY OF NEW HAMPSHIRE | LEWIS-BURKE ASSOCIATES, LLC | 1 | $0 | Q3 2024 | Q3 2024 | yes |